Lantern Pharma  logo

Lantern Pharma LTRN

$ 2.52 4.13%

Annual report 2025
added 03-30-2026

report update icon

Country

usaUSA

IPO year

2020

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

10.9 M

Market Cap[1]

$ 27.5 M

EBITDA (LTM)

$ -16.9 M

P/E (LTM)

-1.48

P/S (LTM)

-

EPS (LTM)

-1.63

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.85 3.22 % $ 9.26 B Nasdaq Capital Market australiaAustralia
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
$ 326.56 -2.05 % $ 42.8 B Nasdaq Global Select Market,SPB usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aligos Therapeutics Aligos Therapeutics
ALGS
$ 7.76 4.51 % $ 76.7 M Nasdaq Global Select Market usaUSA
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 21.48 -0.92 % $ 1 B Nasdaq Global Select Market usaUSA
Burford Capital Limited Burford Capital Limited
BUR
$ 4.7 -0.74 % $ 756 M NYSE britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 3.45 1.32 % $ 347 M Nasdaq Global Select Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 99.42 -0.05 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 3.1 -4.32 % $ 5.1 M NYSE American israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 1.41 -9.12 % $ 363 M Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 4.16 -1.89 % $ 445 M Nasdaq Global Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 24.22 -1.46 % $ 3.08 B Nasdaq Global Select Market,SPB usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.48 -0.67 % $ 394 M Nasdaq Global Select Market britainBritain
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
- -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
- - $ 25.3 M Nasdaq Global Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 33.53 -1.0 % $ 2.23 B Nasdaq Global Select Market usaUSA
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 2.66 -3.34 % $ 1.18 M Nasdaq Capital Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B Nasdaq Global Select Market britainBritain

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.